SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Incorporating species-specific anti-immunoglobulin G (IgG) serum into the hemagglutination-inhibition (HI) test for influenza markedly increased sensitivity without loss of specificity. The effectiveness of anti-IgG serum for augmenting antibody titers may be influenced by the variable potency of commercial anti-IgG preparations. Maximal enhancement of HI titers was achieved when anti-IgG serum and virus-antiserum mixtures were incubated at 23 C for 10 min. Precision and reproducibility of the test were within acceptable limits. Other conditions likely to affect the test were investigated.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Our goal was to recreate a passive hemagglutination inhibition (PHAI) test to diagnose brown recluse spider (BRS; Loxosceles reclusa) bite envenomation for treatment trials. Guinea pigs received intradermal injections of concentrated spider venom from the following species: Loxosceles reclusa, Argiope aurantia, Argiope trifasciata, Phidippus audax, and Lycosa frondicola. Skin lesion exudate was collected and tested with the BRS venom PHAI assay. From 51 separate collections of exudate, test sensitivity was 90% as long as 3 days after venom injection. Specificity was 100% with venom from the other spider species listed above in vivo (7 test samples) and in vitro (5 test samples), as well as with random bacterial exudate with and without added serial dilutions of BRS venom (10 test samples). The test was reproducible over repetitive assays to within one 10-fold dilution. A positive PHAI test result could function as an entry criterion for BRS bite victims in human treatment trials.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
When formalinized instead of fresh goose erythrocytes were used in the hemagglutination (HA) test system of the Akabane virus, the agglutinability of the erythrocytes increased and became less salt-dependent. The improved method based on these findings should facilitate the hemagglutination-inhibition (HI) test and may be useful for epidemiological studies of the Akabane virus.
The enzyme-linked immunosorbent assay (ELISA) and the conventional hemagglutination-inhibition (HI) test were compared for their ability to measure the primary serological response of chickens inoculated by the intranasal-intraocular (IN-IO) routes with Newcastle disease virus (NDV) and the secondary response after intratracheal (IT) challenge. In addition, these responses were compared with the temporal antibody response of chickens inoculated only once by the IT route. Both tests detected NDV-specific antibody by 7 days postinoculation (PI) in the IN-IO-inoculated group, while ELISA and the HI test detected antibody at 4 and 7 days, respectively, in the IT-inoculated group. Titers measured by each test were parallel in quantifying the antibody response, and titers rose anamnestically in response to secondary IT challenge at 21 days PI. ELISA titers remained high at 42 days PI, but the HI titers began to decline at this time. There was a good agreement (R = 0.94) between the results of the two tests throughout both primary and secondary responses. Conversely, there was little agreement between the results of the two tests after 21 days PI in the absence of secondary challenge. Antibody levels were higher when inoculation was by the primary IT route, and they persisted throughout the experiment (86 days). Ciliary activity served as a measure of tracheal immunity or infection of tracheal epithelium. It was reduced as early as 2 days PI and was nearly or completely absent by 5-6 days PI.(ABSTRACT TRUNCATED AT 250 WORDS)
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The prevalence of measles antibody in Japan was surveyed with a newly developed gelatin particle agglutination (PA) test, and the results compared with those of the hemagglutination inhibition (HI) test. The two age-distribution curves of the PA antibody-positive rates at > or = 1:8 and > or = 1:32 were almost the same in all the age groups, except the less-than-1-year-old group for which the rate at > or = 1:8 was higher than that at > or = 1:32 (p < 0.05, chi 2 test). In the vaccinated children, all groups older-than-1-year of age had antibody-positive levels of 96% or more. In contrast, in the unvaccinated children, there was a sharp increase in antibody-positive rates between the 1- and 4-year-old groups, indicative that about 80% of the children were infected by wild measles virus at these ages. A significant number of PA antibody-positive specimens were antibody-negative (< 1:8) by HI. The percentage of specimens in this category, PA (+) but HI (-), was greatest in infants less than one year old, and least in young children, but it increased with age to 97% of the HI (-) specimens from adults of more than 20 years of age. The PA test therefore detected some measles antibodies that HI could not. This test is simple and useful for making serosurveys in both developed and developing countries.